688076 Jiangsu Sinopep-Allsino Biopharmaceutical
- 58.81
- -1.07-1.79%
Jiangsu Sinopep-Allsino Biopharmaceutical News
Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. 2024 Annual Follow-up Rating Report
Nortel Biotech: Reminder Notice on Response to Audit Inquiries on Issuance of Convertible Corporate Bonds to Unspecified Targets and Updates to Application Documents such as Prospectus
Nortel Biotech: Response Report to the Audit Inquiry Letter on the Issuance of Convertible Corporate Bonds Application Documents by Jiangsu Nuotai Auxano Biopharmaceutical Co., Ltd. to Unspecified Targets (Revised Draft)
Response report to the inquiry letter of Zhongtianyun Certified Public Accountants (Special General Partnership) on the application documents for the issuance of convertible corporate bonds by Jiangsu Nuotai Aoxano Biopharmaceutical Co., Ltd. to unspecifie
Response report to the review inquiry letter on the application documents for issuing convertible corporate bonds to unspecified targets by Jiangsu Nuotai Aoxano Biopharmaceutical Co., Ltd.
Response report to the inquiry letter of Zhongtianyun Certified Public Accountants (Special General Partnership) on the application documents for the issuance of convertible corporate bonds by Jiangsu Nuotai Aoxano Biopharmaceutical Co., Ltd. to unspecifie
Nortel Biotech: Reminder Notice on Response to Audit Inquiries on Issuance of Convertible Corporate Bonds to Unspecified Targets and Updates to Application Documents such as Prospectus
Norotai Biotech: Notay Biotech: 2021 Annual Equity Distribution Implementation Notice
Nortel Biotech: 2021 Annual Equity Distribution Implementation Notice
Analysis
Price Target
No Data
